Alpa Laboratories Share Price
Start SIP in Alpa Laboratories
Start SIPAlpa Laboratories Performance
Day Range
- Low 112
- High 115
52 Week Range
- Low 70
- High 145
- Open Price114
- Previous Close114
- Volume16639
Alpa Laboratories Investment Rating
-
Master Rating:
-
Alpa Laboratories has an operating revenue of Rs. 104.75 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 19% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 12% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 21 | 24 | 27 | 32 | 25 | 29 |
Operating Expenses Qtr Cr | 21 | 20 | 25 | 29 | 27 | 20 |
Operating Profit Qtr Cr | 1 | 4 | 2 | 3 | -1 | 9 |
Depreciation Qtr Cr | 1 | 1 | 1 | 0 | 0 | 1 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | 3 | 1 | 0 | 0 | 3 |
Net Profit Qtr Cr | 5 | 4 | 5 | 6 | 3 | 5 |
Alpa Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 10
- Bearish Moving Average
- ___
- 6
- 20 Day
- ₹113.61
- 50 Day
- ₹112.83
- 100 Day
- ₹107.70
- 200 Day
- ₹100.64
- 20 Day
- ₹113.72
- 50 Day
- ₹116.39
- 100 Day
- ₹104.71
- 200 Day
- ₹99.25
Alpa Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | 114.18 |
Second Resistance | 115.59 |
Third Resistance | 116.68 |
RSI | 47.81 |
MFI | 44.43 |
MACD Single Line | -1.46 |
MACD | -1.43 |
Support | |
---|---|
First Support | 111.68 |
Second Support | 110.59 |
Third Supoort | 109.18 |
Alpa Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 21,300 | 2,130,000 | 100 |
Week | 22,349 | 2,234,900 | 100 |
1 Month | 34,383 | 3,438,273 | 100 |
6 Month | 229,721 | 9,198,040 | 40.04 |
Alpa Laboratories Result Highlights
Alpa Laboratories Synopsis
NSE-Medical-Generic Drugs
Alpa Laboratories Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 108.74 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2024. Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446.Market Cap | 239 |
Sales | 105 |
Shares in Float | 0.90 |
No of funds | 5 |
Yield |
Book Value | 1.47 |
U/D Vol ratio | 3.3 |
LTDebt / Equity | 1 |
Alpha | 0.07 |
Beta | 1.27 |
Alpa Laboratories Shareholding Pattern
Owner Name | Sep-24 | Jun-24 | Mar-24 | Dec-23 |
---|---|---|---|---|
Promoters | 57.29% | 57.29% | 57.29% | 57.29% |
Foreign Portfolio Investors | 0.74% | 0.36% | 0.5% | 0.95% |
Individual Investors | 36.09% | 36.65% | 36.84% | 36.84% |
Others | 5.88% | 5.7% | 5.37% | 4.92% |
Alpa Laboratories Management
Name | Designation |
---|---|
Mr. Mahendra Singh Chawla | Chairman |
Mr. Paresh Chawla | Managing Director |
Mrs. Jyoti Jain | Independent Director |
Mr. Pravin Shah | Director |
Mr. Vitthal Kothana | Director |
Mr. Sanket Baheti | Independent Director |
Mr. Shitul Shah | Director |
Mr. Sunil Kumar Valecha | Independent Director |
Mrs. Pratibha Lunawat | Independent Director |
Alpa Laboratories Forecast
Price Estimates
Alpa Laboratories Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-13 | Quarterly Results & A.G.M. | |
2024-05-28 | Audited Results | |
2024-02-13 | Quarterly Results | |
2023-11-07 | Quarterly Results |
Alpa Laboratories FAQs
What is Share Price of Alpa Laboratories ?
Alpa Laboratories share price is ₹112 As on 07 November, 2024 | 21:56
What is the Market Cap of Alpa Laboratories ?
The Market Cap of Alpa Laboratories is ₹237.3 Cr As on 07 November, 2024 | 21:56
What is the P/E ratio of Alpa Laboratories ?
The P/E ratio of Alpa Laboratories is 12.5 As on 07 November, 2024 | 21:56
What is the PB ratio of Alpa Laboratories ?
The PB ratio of Alpa Laboratories is 1.6 As on 07 November, 2024 | 21:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.